Frédéric Honoré

Senior Manager,

Back to Speakers

Frédéric joined Alexion in 2013 and is a trained regulatory affairs professional pharmacist with degrees from Rouen and Paris XI universities (France). Frédéric has a wide range of experience at Alexion Pharmaceuticals in the areas of orphan diseases across several therapeutic areas including hematology, nephrology, neurology and metabolic diseases. In his functions in Global Regulatory Affairs, he has a proven track record of overseeing conduct clinical trials from Phase 1 to commercialization Phase and conduct of involvement in registration of multiple drugs/indications. His drug development experience includes work on Soliris®, Strensiq® and Kanuma®.